67 FR 32 pg. 7205 - Notice of Prospective Patent License
Type: NOTICEVolume: 67Number: 32Page: 7205
Docket number: [Notice 02-025]
FR document: [FR Doc. 02-3686 Filed 2-14-02; 8:45 am]
Agency: National Aeronautics and Space Administration
Official PDF Version: PDF Version
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice 02-025]
Notice of Prospective Patent License
AGENCY:
National Aeronautics and SpaceAdministration.
ACTION:
Notice of prospective patent license.
SUMMARY:
NASA hereby gives notice that CriticalCare Innovations, Inc. having offices in Chantilly, Virginia, has applied for a partially exclusive license to practice the inventions described and claimed in U.S. Patent No.5,827,531, entitled "Multi-Lamellar, Immiscible-Phase Microencapsulation of Drugs"; U.S. Patent No. 6,099,864, entitled "INSITU Activation of Microcapsules"; U.S. Patent No. 6,214,300, entitled "Microencapsulation and ElectrostaticProcessing Device (MEPS)"; U.S. Patent No.6,103,271, entitled "MicroencapsulationElectrostatic Coating Process"; pending U.S. Patent Application entitled "Protein Crystal Encapsulation Process", NASA Case No. MSC-22936-1-SB; pending U.S. Patent Application entitled "Externally Triggered Microcapsules", NASA Case No. MSC-22939-1-SB and pending continuations, divisional applications, and foreign applications corresponding to the above-listed cases. Each of the above-listed patents and patent applications are assigned to the UnitedStates of America as represented by the Administrator of the National Aeronautics andSpace Administration. Written objections to the prospective grant of a license should be sent the Johnson Space Center.
DATES:
Responses to this notice must be received by March 4, 2002.
FOR FURTHER INFORMATION CONTACT:
James Cate,Patent Attorney, NASA Johnson Space Center, MailStop HA, Houston, TX 77058-8452; telephone (281) 483-1001.
Dated: February 8, 2002.
Robert M. Stephens,
Deputy General Counsel.
[FR Doc. 02-3686 Filed 2-14-02; 8:45 am]
BILLING CODE 7510-01-P